Registered entities
Relmada Therapeutics, Inc
Reg. No. 45-5401931United States
RELMADA THERAPEUTICS, INC.
Reg. No. 1553643United States
Social engagement
Social engagement: 3.8K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
3 investors on record; lead investors include BioAdvance, Ben Franklin Technology Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Private equity | 1 | 33% |
Recent activity
29 Jun 2026
Milestone
regulatory
16 Jun 2026
Product launch
NDV-01
12 Jun 2026
Product launch
NDV-01